IL‐6 receptor blockade for allograft dysfunction after lung transplantation in a patient with COPA syndrome

IL‐6 receptor blockade for allograft dysfunction after lung transplantation in a patient with COPA syndrome

Abstract Objective COPA syndrome is a genetic disorder of retrograde cis‐Golgi vesicle transport that leads to upregulation of pro‐inflammatory cytokines (mainly IL‐1β and IL‐6) and the development of interstitial lung disease (ILD). The impact of COPA syndrome on post‐lung transplant (LTx) outcome...

Full description

Bibliographic Details
Main Authors: Peter Riddell, Sajad Moshkelgosha, Liran Levy, Nina Chang, Prodipto Pal, Kieran Halloran, Phil Halloran, Michael Parkes, Lianne G Singer, Shaf Keshavjee, Tereza Martinu, Stephen C Juvet
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Clinical & Translational Immunology
Subjects:
COPA syndrome
IL‐6
lung transplantation
tocilizumab
Online Access:https://doi.org/10.1002/cti2.1243

Internet

https://doi.org/10.1002/cti2.1243

Similar Items